Cervical Cancer Drug Market

The global cervical cancer drug market size was valued at USD 8.25 billion in 2024 and is expected to reach USD 11.96 billion by 2032, at a CAGR of 4.75% during the forecast period This growth is driven by increasing HPV-related cancer prevalence, rising demand for advanced immunotherapies, and growing awareness of cancer screening programs https://www.databridgemarketresearch.com/reports/global-cervical-cancer-drug-market